FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage II... (growths.Interferon alfa-2b has similar a...)

HOME >> BIOLOGY >> TECHNOLOGY

FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma

Date:1/31/2008

growths. Interferon alfa-2b has similar actions to natural interferon. Pegylated interferon alfa-2b is a longer-acting form of interferon made by attaching an inert molecule called polyethylene glycol, or PEG, to the alpha interferon molecule. This modification increases the size of the interferon molecule and results in slower elimination from the body, allowing for less frequent dosing than required for standard interferon.

Peginterferon alfa-2b is not approved for treatment of melanoma. In the United States, peginterferon alfa-2b, marketed as PEGINTRON(TM), is indicated for use alone or with ribavirin for the treatment of chronic hepatitis C in patients with compensated liver disease who have not been previously treated with interferon alpha and who are at least 18 years of age.

In the EU, peginterferon alfa-2b and ribavirin combination therapy is approved for the treatment of chronic hepatitis C who have elevated transaminases without liver decompensation and who are positive for serum HCV-RNA or anti-HCV, including naive patients with clinically stable HIV co-infection and in patients who have failed previous treatment with interferon alpha (pegylated or nonpegylated) and ribavirin combination therapy or interferon alpha monotherapy. Peginterferon alfa-2b had previously received centralized marketing authorization and is marketed as a monotherapy in cases of intolerance or contraindication to ribavirin for the treatment of adult patients with chronic hepatitis C.

In the malignant melanoma trial and other clinical studies, patients receiving peginterferon alfa-2b experienced mild-to-moderate or severe/life-threatening side effects. The most common side effects of peginterferon alfa-2b are: flu-like symptoms, including headache, fatigue, aches and pains, fevers and chills; depression, nausea, loss of appetite and diarrhea; insomnia; alopecia (hair loss); a reaction at the site of injection; changes in blood liver function tests and in blood c
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related biology technology :

1. Mirus Bio Awarded Grants & Contracts of Over $5 Million
2. FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
3. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
4. NIH grants $750,000 to develop device to determine temperature of neonates brain
5. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
6. Radius Grants Major Pharmaceutical Company Exclusive Option to License BA058 for Osteoporosis
7. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
8. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
9. NASDAQ Panel Grants Merge Technologies Additional Time to Regain Compliance
10. FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208
11. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants

Post Your Comments:

(Date:6/19/2013)... Clinverse, Inc. , a global ... today announced it will be exhibiting and showcasing ... Boston, June 24-26, 2013. Clinverse’s eClinical Commerce ... configurable, cloud-based clinical financial lifecycle system. , Clinverse’s ... eClinical Commerce Network, automates site contract set-up and ...

(Date:6/19/2013)... 19, 2013 NineSigma , Inc., of ... following its launch, NineSights.com is now the ... for the worldwide community of innovators. From ... sustainability experts, NineSights stands out for its large community ... and technical disciplines, all vetted by NineSigma. The community ...

(Date:6/19/2013)... India , June 19, ... Bharat Book Bureau presents Innovative ... and Formulation Technology Licensing Opportunities ... http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/innovative-drug-delivery-systems-novel-product-and-formulation-technology-licensing-opportunities-for-generic-pharmaceutical-companies.html ) There ... or controlled release drugs approved ...

(Date:6/19/2013)... 18, 2013 A new look at ... and other trends will highlight technical sessions at ... fall. In its 33rd year, the three-day event is ... of key suppliers, approximately 100 technical presentations and numerous ... international society for optics and photonics , the meeting ...

Breaking Biology Technology:Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013 2 NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 2 NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 3 Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2 Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3 ‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2 ‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3

[0] Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013 [0] NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights [0] Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies [0] ‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology

... (Nasdaq: PRXL ), a leading global ... Ltd, today announced,that it has been recognized ... as,the winner of its Most Innovative Patient ... collaborative efforts of PAREXEL and study,sponsor Glenmark, ...

... AMSTERDAM, October 29 Avantium announced today ... private financing round. Avantium,is active in the ... biofuel and bioplastic, and the improvement of,pharmaceutical ... accelerate its two,proprietary development programs. The focus ...

... Oct. 29 ,Shire plc (LSE: SHP, Nasdaq: SHPGY) the global specialty ... Q3 2008 Financial Highlights, - Product sales up ... up 51% to $444 million - New product sales(1) $276 ... - Total revenues up 28% to $779 million - Non ...

PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy Avantium Completes EUR 18 Million Financing Round Shire's New Product Portfolio Delivers Strong Quarterly Performance

(Date:6/19/2013)... , June 19, 2013 New York College of ... United States Patent and Trademark Office for detecting biometric ... reflect whether guards have been injured, attacked or killed. ... portfolio under the Intellectual Properties Agreements of New York ... , President of New York ...

(Date:6/19/2013)... Elsevier, a world-leading provider of scientific, technical and medical ... launch of a new open access journal, GeoResJ ... , Elsevier,s earth and planetary science journals portfolio has ... to provide a forum for rapid publication of top ... will be co-edited by six Executive Editors, each covering ...

(Date:6/18/2013)... UT Arlington environmental engineer has been awarded a ... to ensure water quality and flow in the ... , Andrew Kruzic, UT Arlington associate professor of ... locations to add monochloramine to the water in ... new pump stations and pipelines. Adding monochloramine is ...

Breaking Biology News(10 mins):New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 2 New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 3 New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 4 UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2

[0] New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed [0] Elsevier launches open access journal: GeoResJ [0] UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline

... 2 emissions from using coal are set to double by ... mitigating global climate change. In view of the essential role ... emissions where coal is used. The British Geological ... (NZEC) Phase 1 study in Beijing, China today. The aim of ...

... small amounts of lead in children,s blood -- amounts ... with reduced IQ scores, finds a new six-year Cornell ... on cognitive function in children whose blood-lead levels (BLLs) ... (CDC) standard of 10 micrograms per deciliter (mcg/dl) -- ...

... dengue cause suffering and death around the world. ... and is particularly devastating in children under the age ... these diseases consume vast economic resources in the very ... to controlling these diseases such as insecticides, vaccine development, ...

Cached Biology News:UK scientists lead China closer to carbon capture and storage 2 Even minute levels of lead cause brain damage in children 2 Selfish DNA and the Genetic Control of Vector-Borne Diseases 2 Selfish DNA and the Genetic Control of Vector-Borne Diseases 3

UK scientists lead China closer to carbon capture and storage Even minute levels of lead cause brain damage in children Selfish DNA and the Genetic Control of Vector-Borne Diseases

Mouse polyclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = 25797...

... against a partial recombinant IFNA2. Immunogen: ... protein is produced in E. coli. The ... mg. OMIM: 147562, ... MM951100564 MA Code: ABV0P9DPB ...

... Researchers no longer need to perform time consuming ... With Mutation Surveyor, any found variants of the ... clearly indicated in our mutation electropherogram as a ... the bi-directional analysis mode is over 99%, with ...

...

Biology Products:

Mouse Anti-Human QPCT Polyclonal Antibody, Unconjugated from Abnova Corporation Mouse Anti-IFNA2 Monoclonal Antibody, Unconjugated, Clone 1F11 from Abnova Corporation Mutation Surveyor from SoftGenetics, LLC.Finnigan LTQ FT from Thermo Scientific